Risk factor
Good trading liquidity
Profitability factor
Very strong margins and returns
About
Amoy Diagnostics Co., Ltd. is a Chinese company focused on oncology precision medicine. It engages in the research, development, production, and sale of molecular diagnostic products. The company provides a range of diagnostic reagents and testing services that help identify genetic mutations and biomarkers, which are used to guide personalized cancer treatment.
Company Valuation
Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. In particular, the stock is reasonably priced on P/E, of fair value on
Target Price
The average target price of 300685.SZ is 26.9 and suggests 32.5% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to